Fortunately, there is no shortage of targets in BC cells, and studies have shown that specific markers, including PD1, MUC1, and EGFR, are highly expressed in BC cancer cells and can serve as potential therapeutic targets [94]. Here, PDCD1 is linked to breast cancer.